Cargando…
Discontinuation of biologic DMARDs in non-systemic JIA patients: a scoping review of relapse rates and associated factors
BACKGROUND: Biologic disease-modifying antirheumatic drugs (bDMARDs) have changed the treatment of juvenile idiopathic arthritis (JIA) patients notably, as bDMARDs enable substantially more patients to achieve remission. When sustained remission is achieved, tapering or even discontinuation of the b...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721079/ https://www.ncbi.nlm.nih.gov/pubmed/36471348 http://dx.doi.org/10.1186/s12969-022-00769-5 |